Establishment and characterization of a cell line (IGSK-3) secreting human chorionic gonadotropin, adrenocorticotropic hormone and parathyroid hormone-related protein derived from primary poorly differentiated adenocarcinoma of the stomach

We recently established human chorionic gonadotropin-, adrenocorticotropic hormone- and parathyroid hormone-related protein-secreting cell line derived from primary poorly differentiated adenocarcinoma of the stomach. The cell line was designated as IGSK-3. Inverted-phase contrast microscopy reveale...

Full description

Saved in:
Bibliographic Details
Published inHuman cell : official journal of Human Cell Research Society Vol. 21; no. 3; pp. 88 - 94
Main Authors Yamashita, Shigeo, Takahashi, Naoto, Hashimoto, Hisashi, Tachibana, Toshiaki, Nakahara, Taka, Ohyama, Akihiro, Yanaga, Katsuhiko
Format Journal Article
LanguageEnglish
Published Tokyo Springer-Verlag 01.08.2008
Blackwell Publishing Asia
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We recently established human chorionic gonadotropin-, adrenocorticotropic hormone- and parathyroid hormone-related protein-secreting cell line derived from primary poorly differentiated adenocarcinoma of the stomach. The cell line was designated as IGSK-3. Inverted-phase contrast microscopy revealed that the IGSK-3 cells consist of two morphological subtypes. One type has visible nucleoli and clear nuclei, but nucleoli and nuclear membrane of the othertype are invisible. The population-doubling time was about 43 h. An analysis of conditioned medium by IGSK-3 cells cultured for 4 days revealed the IGSK-3 cells secrete human chorionic gonadotropin-β (0.5 ng/mL), adrenocorticotropic hormone (5.5 pg/mL), parathyroid hormone-related protein (3.4 pmol/mL) and epidermal growth factor (14.2 pg/mL). Histopathological diagnosis of the graft of IGSK-3 cells revealed that IGSK-3 cells built a poorly differentiated adenocarcinoma which resembled the original tumor. In addition, the IGSK-3 cell line was immunocytochemically positive for human chorionic gonadotropin-β and epidermal growth factor receptor, and negative for vascular endothelial growth factor.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0914-7470
1749-0774
DOI:10.1111/j.1749-0774.2008.00054.x